1482 Results for
- View:
- Only Recruiting Trials
-
All Trials
| Study Title | Principal Investigator |
|---|---|
|
A Randomized, Placebo Controlled Phase 2b/3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance 1)
Not recruiting | Brain Cancer | Multisite
|
|
Powered by
SC CTSI